The forecast for the import of pharmaceutical goods to Brazil shows a consistent increase over the next five years. Starting with a value of 202.79 million USD in 2024, the import value is projected to rise to 216.29 million USD by 2028. This represents a cumulative growth with year-on-year variations reflecting an upward trend. To put this in perspective, the import value for pharmaceutical goods stood at [Value in 2023] million USD in 2023.
Year-on-year variations show the following percentage increases: from 2024 to 2025, an increase of approximately 1.72%, from 2025 to 2026, an increase of about 1.65%, from 2026 to 2027, an increase of around 1.60%, and from 2027 to 2028, an increase of approximately 1.53%. Over the last five years, the Compound Annual Growth Rate (CAGR) is projected to be around 1.62%, indicating a steady growth trajectory in the import of pharmaceutical goods.
Future trends to watch for include shifts in global pharmaceutical supply chains, potential regulatory changes in Brazil that could affect import tariffs or quotas, and the overall economic health of the country which could impact consumer spending on healthcare. Additionally, technological advancements in pharmaceuticals and the ongoing impact of global health issues may also play significant roles in shaping import trends.
